Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Breast Cancer Research and Treatment|September 25, 2016
Treatment with aromatase inhibitors and markers of cardiovascular diseaseEva Blondeaux, Debora Musio, Paolo Bruzzi, et al.European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.Frontiers in Oncology|June 21, 2021
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast CancerEva Blondeaux, Claudia Massarotti, Valeria Fontana, et al.Cancer Treatment Reviews|February 5, 2023
Germline TP53 pathogenic variants and breast cancer: A narrative reviewEva Blondeaux, Luca Arecco, Kevin Punie, et al.BMC Cancer|May 21, 2017
The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patientsMatteo Lambertini, Paola Anserini, Valeria Fontana, et al.Frontiers in Oncology|July 30, 2026
Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patientsCaterina Gianni, Emanuela Scarpi, Eva Blondeaux, et al.Journal of the National Cancer Institute|December 1, 2021
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer PatientsMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.ESMO Open|August 21, 2020
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort studyEva Blondeaux, Arlindo R Ferreira, Francesca Poggio, et al.British Journal of Cancer|April 2, 2020
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 studyEva Blondeaux, Matteo Lambertini, Andrea Michelotti, et al.Breast (Edinburgh, Scotland)|February 6, 2026
Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysisChiara Dauccia, Marco Bruzzone, Luca Arecco, et al.Pageof 6